Submitted by Anonymous (not verified) on 2 June 2025 - 15:50
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 67, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 67, Status: Authorised